慢性肾脏病进展期间血糖状态与糖尿病患者早期透析死亡率的关联
该研究纳入17819例2007年10月至2011年9月期间从糖尿病合并慢性肾脏病过渡到透析的美国退伍军人,分析透析前1年平均糖化血红蛋白和随机血糖与透析后第一年死亡率的关系。结果显示糖化血红蛋白≥8%和随机血糖≥200 mg/dL与透析后第一年死亡率升高相关,且血糖水平越高心血管死亡率也越高。
要点
- 透析前1年平均糖化血红蛋白≥8%与透析后第一年全因死亡率升高相关。
- 透析前1年平均随机血糖≥200 mg/dL与透析后第一年全因死亡率升高相关。
- 平均糖化血红蛋白和随机血糖越高,心血管死亡率也越高。
核心结论
- 在糖尿病合并慢性肾脏病过渡到透析的患者中,透析前终末期肾病前期较高的平均糖化血红蛋白和随机血糖水平与透析后第一年死亡率升高相关。
- 作者认为需要开展临床试验来检验调节血糖状态能否改善该人群的生存。
研究设计与样本
- 研究纳入17819例2007年10月至2011年9月期间从糖尿病合并慢性肾脏病过渡到透析的美国退伍军人。
- 研究分析透析前1年平均糖化血红蛋白和随机血糖水平与透析开始后第一年死亡率的关系。
- 全因死亡风险比采用多变量生存模型估计,次要分析采用竞争风险方法评估心血管死亡。
主要发现
- 与参考值糖化血红蛋白6%至<7%(42-53 mmol/mol)相比,糖化血红蛋白8%至<9%(64-75 mmol/mol)的调整风险比为1.19(95%CI 1.07-1.32),糖化血红蛋白≥9%(≥75 mmol/mol)的调整风险比为1.48(95%CI 1.31-1.67)。
- 与参考值随机血糖100至<125 mg/dL相比,随机血糖≥200 mg/dL的调整风险比为1.34(95%CI 1.20-1.49)。
- 累积发病率曲线显示,平均糖化血红蛋白和随机血糖水平越高,心血管死亡率也越高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although early trials suggested that intensive glycemic targets reduce the number of complications with diabetes, contemporary trials indicate no cardiovascular benefit and potentially higher mortality risk. As patients with advanced chronic kidney disease (CKD) transitioning to treatment with dialysis were excluded from these studies, the optimal glycemic level in this population remains uncertain. We hypothesized that glycemic status, defined by hemoglobin A1c (HbA--1c) and random glucose levels, in the pre-end-stage renal disease (ESRD) period is associated with higher 1-year post-ESRD mortality among patients with incident diabetes who have ESRD. RESEARCH DESIGN AND METHODS: Among 17,819 U.S. veterans with diabetic CKD transitioning to dialysis from October 2007 to September 2011, we examined the association of mean HbA--1c and random glucose levels averaged over the 1-year pre-ESRD transition period with mortality in the first year after dialysis initiation. All-cause mortality hazard ratios (HRs) were estimated using multivariable survival models. Secondary analyses examined cardiovascular mortality using competing risks methods. RESULTS: HbA--1c levels ≥8% (≥64 mmol/mol) were associated with higher mortality in the first year after dialysis initiation (reference value 6% to <7% [42-53 mmol/mol]): adjusted HRs [aHRs] 1.19 [95% CI 1.07-1.32] and 1.48 (1.31-1.67) for HbA--1c 8% to <9% [64-75 mmol/mol] and ≥9% [≥75 mmol/mol], respectively). Random glucose levels ≥200 mg/dL were associated with higher mortality (reference value 100 to <125 mg/dL): aHR 1.34 [95% CI 1.20-1.49]). Cumulative incidence curves showed that incrementally higher mean HbA--1c and random glucose levels were associated with increasingly higher cardiovascular mortality. CONCLUSIONS: In patients with diabetes and CKD transitioning to dialysis, higher mean HbA--1c and random glucose levels during the pre-ESRD prelude period were associated with higher 1-year post-ESRD mortality. Clinical trials are warranted to examine whether modulating glycemic status improves survival in this population.
引用
- Rhee CM, Kovesdy CP, Ravel VA, et al. Association of Glycemic Status During Progression of Chronic Kidney Disease With Early Dialysis Mortality in Patients With Diabetes. Diabetes Care. 2017. PMID: 28592525. doi:10.2337/dc17-0110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。